Immune cells and inflammatory processes play major roles in PH (14, 47–49), and recent evidence indicates that ActRIIA-Fc suppresses inflammation as one component of its multi-factorial mechanism of action in experimental PAH (16). The gene discussed is ACVR2A; the disease is pulmonary arterial hypertension.